Abstract
Sirolimus-eluting stent (SES) implantation has been shown to reduce repeat revascularization in various randomized trials. The present study evaluated the outcomes after SES implantation in 46 octogenarian patients. SES implantation in octogenarians appears to be feasible and is associated with very small subsequent need for repeat target vessel revascularization at 1 year.
Publication types
-
Evaluation Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Aged, 80 and over
-
Angioplasty, Balloon, Coronary
-
Blood Vessel Prosthesis Implantation
-
Coated Materials, Biocompatible / therapeutic use*
-
Combined Modality Therapy
-
Coronary Artery Disease / therapy*
-
Female
-
Follow-Up Studies
-
Hospital Mortality
-
Humans
-
Immunosuppressive Agents / therapeutic use*
-
Male
-
Netherlands
-
Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
-
Platelet Glycoprotein GPIIb-IIIa Complex / therapeutic use
-
Postoperative Complications / etiology
-
Postoperative Complications / mortality
-
Sirolimus / therapeutic use*
-
Stents*
-
Treatment Outcome
Substances
-
Coated Materials, Biocompatible
-
Immunosuppressive Agents
-
Platelet Glycoprotein GPIIb-IIIa Complex
-
Sirolimus